 Home > Active Ingredient News > Drugs Articles > Express delivery potential amount exceeds 1.2 billion U.S. dollars, Sanofi acquires tumor immunotherapy development company

Express delivery potential amount exceeds 1.2 billion U.S. dollars, Sanofi acquires tumor immunotherapy development company

 Last Update: 2022-01-09
 Source: Internet
 Author: User

Tags

military technology advances

fosamax half life

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

A few days ago, Sanofi announced that it has reached an agreement to acquire Amunix Pharmaceuticals

The acquisition will expand Sanofi's T-cell conjugator (TCE) and cytokine therapy pipeline

The protease release stealth Pro-XTEN (Protease-Releasable Masking Technology) technology platform developed by Amunix utilizes the inherent high protease activity in the tumor microenvironment to preferentially activate drugs, thereby reducing toxicity without affecting normal tissues

Take advantage of the inherent high protease activity in the tumor microenvironment to preferentially activate drugs, thereby reducing toxicity without affecting normal tissues

▲Pro-XTEN-XPAT-XPAC technology platform composition principle (picture source: Amunix company official website)

Amunix has further developed a new bispecific XPAT platform by using the clinically proven XTEN technology, which can deliver bispecific antibodies to patients in lower doses, thereby reducing toxic side effects

It can deliver bispecific antibodies to patients in lower doses, thereby reducing toxic side effects

▲XPAT technology platform (picture source: Amunix company official website)

Dr.

The Amunix technology platform uses the next generation of smart biological product methods to achieve precise customized delivery of drugs

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Reta 5mg 10mg 15mg Vial Weight Loss Anti-diabetes Fat Loss

CAS No.: 2381089-83-2

Pharmacy Grade

$110-130/UNIT FOB

Best price Pure Tirzepatide powder 10mg vial Tirzepatide CAS 2023788-19-2 ouda

CAS No.: 2023788-19-2

Pharmacy Grade

$40.00/G FOB

Hot Sale 1-Adamantanamine Hydrochloride /1-Adamantanamine HCl CAS 665-66-7

CAS No.: 665-66-7

Pharmacy Grade

$20-25/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.